<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Hemeonc • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Hemeonc • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/Hemeonc/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/Hemeonc/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="hemeonc" tabindex="-1">Hemeonc</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<ul>
<li><a href="/wiki/notes/management%20of%20bone%20metastasis/">management of bone metastasis</a></li>
<li><a href="/wiki/notes/Hematopoietic%20Stem%20Cells%20and%20Their%20Disorders/">Hematopoietic Stem Cells and Their Disorders</a></li>
<li><a href="/wiki/notes/Multiple%20Myeloma%20and%20Related%20Disorders/">Multiple Myeloma and Related Disorders</a></li>
<li><a href="/wiki/notes/Erythrocyte%20Disorders/">Erythrocyte Disorders</a></li>
<li><a href="/wiki/notes/Iron%20Overload%20Syndromes/">Iron Overload Syndromes</a></li>
<li><a href="/wiki/notes/Platelet%20Disorders/">Platelet Disorders</a></li>
<li><a href="/wiki/notes/MKSAP%20Bleeding%20Disorders/">MKSAP Bleeding Disorders</a></li>
<li><a href="/wiki/notes/MKSAP%20Transfusion%20Medicine/">MKSAP Transfusion Medicine</a></li>
<li><a href="/wiki/notes/Thrombotic%20Disorders/">Thrombotic Disorders</a></li>
<li><a href="/wiki/notes/Hematologic%20Issues%20in%20Pregnancy/">Hematologic Issues in Pregnancy</a></li>
<li><a href="/wiki/notes/Issues%20in%20Oncology/">Issues in Oncology</a></li>
<li><a href="/wiki/notes/Breast%20Cancer/">Breast Cancer</a></li>
<li><a href="/wiki/notes/Ovarian%20Cancer/">Ovarian Cancer</a></li>
<li><a href="/wiki/notes/MKSAP%20Cervical%20Cancer/">MKSAP Cervical Cancer</a></li>
<li><a href="/wiki/notes/Gastroenterological%20Malignancies/">Gastroenterological Malignancies</a></li>
<li><a href="/wiki/notes/Lung%20Cancer/">Lung Cancer</a></li>
<li><a href="/wiki/notes/Head%20and%20Neck%20Cancer/">Head and Neck Cancer</a></li>
<li><a href="/wiki/notes/Genitourinary%20Cancer/">Genitourinary Cancer</a></li>
<li><a href="/wiki/notes/Lymphoid%20Malignancies/">Lymphoid Malignancies</a></li>
<li><a href="/wiki/notes/Cancer%20of%20Unknown%20Primary%20Site/">Cancer of Unknown Primary Site</a></li>
<li><a href="/wiki/notes/Melanoma/">Melanoma</a></li>
<li><a href="/wiki/notes/Oncologic%20Urgencies%20and%20Emergencies/">Oncologic Urgencies and Emergencies</a></li>
<li><a href="/wiki/notes/Effects%20of%20Cancer%20Therapy%20and%20Survivorship/">Effects of Cancer Therapy and Survivorship</a></li>
</ul>
<h2 id="heme" tabindex="-1">Heme</h2>
<ul>
<li><a href="/wiki/notes/coagulation%20cascade/">coagulation cascade</a></li>
<li><a href="/wiki/notes/anticoagulation%20agents/">anticoagulation agents</a></li>
<li><a href="/wiki/notes/Anemia/">Anemia</a></li>
<li><a href="/wiki/notes/DVT%20and%20PE/">DVT and PE</a></li>
<li><a href="/wiki/notes/Hemochromatosis/">Hemochromatosis</a></li>
<li><a href="/wiki/notes/Sickle%20cell%20disease/">Sickle cell disease</a></li>
<li><a href="/wiki/notes/warfarin/">warfarin</a></li>
<li><a href="/wiki/notes/blood%20smear/">blood smear</a></li>
<li><a href="/wiki/notes/polycythemia%20vera/">polycythemia vera</a></li>
<li><a href="/wiki/notes/essential%20thrombocytosis/">essential thrombocytosis</a></li>
<li><a href="/wiki/notes/anemia%20lecture/">anemia lecture</a></li>
<li><a href="/wiki/notes/autoimmune%20hemolytic%20anemia/">autoimmune hemolytic anemia</a></li>
<li><a href="/wiki/notes/supratherapeutic%20INR/">supratherapeutic INR</a></li>
<li><a href="/wiki/notes/myelofibrosis/">myelofibrosis</a></li>
<li><a href="/wiki/notes/perioperative%20management%20of%20von%20willebrand%20disease%20vwd%20vwf/">perioperative management of von willebrand disease vwd vwf</a></li>
<li><a href="/wiki/notes/comparing%20different%20anticoagulants,%20warfarin,%20coumadin,%20doacs/">comparing different anticoagulants, warfarin, coumadin, doacs</a></li>
</ul>
<h3 id="acute-bleeding-and-reversal" tabindex="-1">Acute bleeding and reversal</h3>
<ul>
<li>
<p><a href="/wiki/notes/acute%20bleeding%20classifications/">acute bleeding classifications</a></p>
<ul>
<li><a href="/wiki/notes/transfusing%20chronical%20anemic%20patients%20to%20hemoglobin%20goal%20can%20cause%20worsening%20symptoms%20or%20even%20death/">transfusing chronical anemic patients to hemoglobin goal can cause worsening symptoms or even death</a></li>
<li><a href="/wiki/notes/massive%20transfusion%20protocol/">massive transfusion protocol</a></li>
</ul>
</li>
<li>
<p><a href="/wiki/notes/ITP/">ITP</a></p>
</li>
<li>
<p><a href="/wiki/notes/TTP/">TTP</a></p>
</li>
<li>
<p><a href="/wiki/notes/acquired%20coagulation%20factor%20inhibitors/">acquired coagulation factor inhibitors</a></p>
</li>
<li>
<p><a href="/wiki/notes/Bleeding%20disorders%20overview/">Bleeding disorders overview</a></p>
</li>
<li>
<p><a href="/wiki/notes/heparin%20induced%20thrombocytopenia/">heparin induced thrombocytopenia</a></p>
</li>
<li>
<p><a href="/wiki/notes/disseminated%20intravascular%20coagulation/">disseminated intravascular coagulation</a></p>
</li>
<li>
<p><a href="/wiki/notes/DIC%20vs%20liver%20disease/">DIC vs liver disease</a></p>
</li>
<li>
<p><a href="/wiki/notes/transfusion%20medicine/">transfusion medicine</a></p>
</li>
<li>
<p><a href="/wiki/notes/anticoagulation%20reversal/">anticoagulation reversal</a></p>
</li>
<li>
<p><a href="/wiki/notes/use%20mixing%20studies%20to%20differentiate%20deficiency%20vs%20inhibitors/">use mixing studies to differentiate deficiency vs inhibitors</a></p>
</li>
</ul>
<h3 id="lectures" tabindex="-1">Lectures</h3>
<ul>
<li><a href="/wiki/notes/icu%20lecture%20coagulopathy%20and%20bleeding/">icu lecture coagulopathy and bleeding</a></li>
</ul>
<h3 id="literature-notes" tabindex="-1">Literature Notes</h3>
<ul>
<li><a href="/wiki/notes/ibcc%20anemia,%20bleeding,%20transfusion/">ibcc anemia, bleeding, transfusion</a></li>
<li><a href="/wiki/notes/ibcc%20massive%20transfusion%20protocol/">ibcc massive transfusion protocol</a></li>
</ul>
<h2 id="oncology" tabindex="-1">Oncology</h2>
<ul>
<li><a href="/wiki/notes/Paget%20disease/">Paget disease</a></li>
<li><a href="/wiki/notes/prostate%20cancer/">prostate cancer</a></li>
<li><a href="/wiki/notes/febrile%20neutropenia/">febrile neutropenia</a></li>
<li><a href="/wiki/notes/leukostasis/">leukostasis</a></li>
<li><a href="/wiki/notes/tumor%20lysis%20syndrome/">tumor lysis syndrome</a></li>
<li><a href="/wiki/notes/prevention%20of%20recurrent%20VTE%20in%20cancer%20patients/">prevention of recurrent VTE in cancer patients</a></li>
<li><a href="/wiki/notes/metastatic%20colon%20cancer%20to%20liver/">metastatic colon cancer to liver</a></li>
<li><a href="/wiki/notes/anterior%20mediastinal%20mass/">anterior mediastinal mass</a></li>
<li><a href="/wiki/notes/long%20term%20complications%20of%20non%20hodgkin%20lymphoma/">long term complications of non hodgkin lymphoma</a></li>
<li><a href="/wiki/notes/treat%20solitary%20lung%20brain%20mets%20with%20surgical%20resection/">treat solitary lung brain mets with surgical resection</a></li>
</ul>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        <nav class="toc" >
        <ul><li><a href="#mksap">MKSAP</a></li><li><a href="#heme">Heme</a><ul><li><a href="#acute-bleeding-and-reversal">Acute bleeding and reversal</a></li><li><a href="#lectures">Lectures</a></li><li><a href="#literature-notes">Literature Notes</a></li></ul></li><li><a href="#oncology">Oncology</a></li></ul>
      </nav>
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/ITP/" class="peer">ITP</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="itp" tabindex="-1">ITP</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<!-- ITP management -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20200906125013_.png" alt=""></p>
<ul>
<li>Patients with asymptomatic mild thrombocytopenia (platelets &gt;30,000/µL without bleeding) can generally be observed without treatment.</li>
<li><strong>Corticosteroids</strong> are a first-line treatment option for patients with symptoms and/or a platelet count of &lt;30,000/µL; the majority of adults respond within 1-2 weeks.</li>
<li><strong>Intravenous immunoglobulin</strong> can be cons</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Anemia/" class="peer">Anemia</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="anemia" tabindex="-1">Anemia</h1>
<ul>
<li><a href="/wiki/notes/ineffective%20erythropoiesis/">ineffective erythropoiesis</a>, <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<h2 id="microcytic-anemia" tabindex="-1">Microcytic anemia</h2>
<!-- microcytic anemia types, dx differences --> 
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/image-20200717143725483.png" alt=""></p>
<h2 id="thalassemia" tabindex="-1">Thalassemia</h2>
<!-- thalassemia rdw, iron studies -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/image-20200118105157741.png" alt=""></p>
<p>Screening for anemia is routine at the first prenatal visit. Patients with thalassemia minor (ie, thalassemia trait) have mild **micr</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Bleeding disorders overview/" class="peer">Bleeding Disorders Overview</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="bleeding-disorders-overview" tabindex="-1">Bleeding disorders overview</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20211205110156.png" alt=""></p>
<!-- intrinsic vs extrinsic bleeding disorders -->
<ul>
<li>Intrinsic bleeding disorder
<ul>
<li>prolonged PTT</li>
<li>hemophilia A(8)/B: nl PT, bleeding time, plt count
<ul>
<li>replace with DDAVP and aminocaproic acid for hemophilia A</li>
<li>can also give factor 8</li>
</ul>
</li>
<li>vWF: increased PTT and bleeding time
<ul>
<li>riscocetin test for diagnosis</li>
<li>DDAVP and am</li>
</ul>
</li>
</ul>
</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Bleeding disorders/" class="peer">Bleeding Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="bleeding-disorders" tabindex="-1">Bleeding disorders</h1>
<ul>
<li>
<p>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></p>
</li>
<li>
<p><a href="/wiki/notes/ITP/">ITP</a></p>
</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220615144524.png" alt=""></p>
<p>Prolonged aPTT and normal PT (INR) suggest an intrinsic pathway defect.  Deficiencies of factor XII, prekallikrein, or high molecular weight kininogen all cause a prolonged aPTT without clinical bleeding.  Prolonged aPTT with bleeding can occur in congenital or acquired von Willebrand disease and isolated deficiencies of factors VIII, IX, a</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/DVT and PE/" class="peer">DVT and PE</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="dvt-and-pe" tabindex="-1">DVT and PE</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>It is unusual for an otherwise healthy 37-year-old to suddenly develop a DVT, especially in the absence of any recent provoking factors such as  trauma, surgery, or a long plane trip. The sudden death of this  patient's paternal uncle at a young age should raise a red flag that he  may have an inherited hypercoagulable condition. The most common cause  of inherited thrombophilia (accounting for approximately 50% of c</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Medicine/" class="peer">Medicine</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="medicine" tabindex="-1">Medicine</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/000%20Index/">000 Index</a></li>
<li>Related: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Step%201/">Step 1</a>, <a href="/wiki/notes/mksap/">mksap</a>, <a href="/wiki/notes/notes/">notes</a></li>
</ul>
<h2 id="todos" tabindex="-1">Todos</h2>
<ul>
<li><a href="/wiki/notes/tolearn/">tolearn</a></li>
<li>MKSAP todos
<ul>
<li>heart murmurs</li>
</ul>
</li>
</ul>
<h2 id="organ-systems" tabindex="-1">Organ Systems</h2>
<ul>
<li><a href="/wiki/notes/Allergy%20and%20Immunology/">Allergy and Immunology</a></li>
<li><a href="/wiki/notes/Rheumatology/">Rheumatology</a></li>
<li><a href="/wiki/notes/Cardiology/">Cardiology</a></li>
<li><a href="/wiki/notes/Dermatology/">Dermatology</a></li>
<li><a href="/wiki/notes/Endocrine/">Endocrine</a></li>
<li><a href="/wiki/notes/ENT/">ENT</a></li>
<li><a href="/wiki/notes/GI/">GI</a></li>
<li><a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li><a href="/wiki/notes/ID/">ID</a></li>
<li><a href="/wiki/notes/MSK/">MSK</a></li>
<li><a href="/wiki/notes/Nephrology/">Nephrology</a></li>
<li><a href="/wiki/notes/Urology/">Urology</a></li>
<li><a href="/wiki/notes/Neurology/">Neurology</a></li>
<li><a href="/wiki/notes/Pulmonology/">Pulmonology</a></li>
<li><a href="/wiki/notes/Podiatry/">Podiatry</a></li>
</ul>
<h2 id="subject-areas" tabindex="-1">Subject Areas</h2>
<ul>
<li><a href="/wiki/notes/General/">General</a></li>
<li><a href="/wiki/notes/Biostats/">Biostats</a></li>
<li><a href="/wiki/notes/Psychiatry/">Psychiatry</a></li>
<li>[[Geriatric</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/transfusion goals/" class="peer">Transfusion Goals</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="transfusion-goals" tabindex="-1">transfusion goals</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #literature</li>
<li>source: <a href="https://www.acpjournals.org/doi/10.7326/0003-4819-157-1-201206190-00429">Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB</a></li>
</ul>
<hr>
<ul>
<li><a href="/wiki/notes/transfuse%20rbc%20for%20goal%20of%207%20for%20stable%20hospitalized%20patients%20or%208%20for%20cardiac%20or%20surgical%20patients/">transfuse rbc for goal of 7 for stable hospitalized patients or 8 for cardiac or surgical patients</a></li>
</ul>
<h2 id="tricc-and-pocus" tabindex="-1">TRICC and POCUS</h2>
<ul>
<li>transfusion goal of 7 for stable patients in hospital</li>
<li>transfusion goal of 8 or if symptoms for preexisting CV disease patie</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/transfusion medicine/" class="peer">Transfusion Medicine</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="transfusion-medicine" tabindex="-1">Transfusion Medicine</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<hr>
<ul>
<li><a href="/wiki/notes/transfusion%20products/">transfusion products</a></li>
<li><a href="/wiki/notes/transfusion%20goals/">transfusion goals</a></li>
<li><a href="/wiki/notes/transfusion%20reaction/">transfusion reaction</a></li>
<li><a href="/wiki/notes/massive%20transfusion%20protocol/">massive transfusion protocol</a></li>
</ul>
<h2 id="transfusion-rate" tabindex="-1">Transfusion Rate</h2>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220208105235.png" alt=""></p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/warfarin/" class="peer">Warfarin</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="warfarin" tabindex="-1">Warfarin</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/INR%20goals/">INR goals</a></li>
</ul>
<hr>
<!-- warfarin reversal how -->
<p><strong>Warfarin</strong> is an anticoagulant commonly used in the treatment of atrial fibrillation and venous thromboembolism.  Effects arise from the inhibition of vitamin K recycling, which reduces circulating levels of vitamin K-dependent clotting factors II, VII, IX, and X.  The major risk of therapy is bleeding-associated complications, particularly <strong>intracranial hemorrhage</strong>.</p>
<p>Patients on warfa</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/heparin induced thrombocytopenia/" class="peer">Heparin Induced Thrombocytopenia</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="heparin-induced-thrombocytopenia-and-thrombosis" tabindex="-1">heparin induced thrombocytopenia and thrombosis</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="type-1-hitt" tabindex="-1">type 1 HITT</h2>
<ul>
<li>within 2 days of initiating heparin</li>
<li>transient, non pathologic</li>
<li>Plt &gt; 100k</li>
<li>Do not stop heparin, plt will return to normal</li>
</ul>
<h2 id="type-2-hitt" tabindex="-1">type 2 HITT</h2>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220809211059.png" alt=""></p>
<ul>
<li>antibody against PF4 =&gt; activates Plt =&gt; plt cascades =&gt; thrombosis and thrombocytopenia</li>
<li>risks
<ul>
<li>women</li>
<li>most often unfractionated heparin</li>
<li>CV</li>
</ul>
</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/febrile neutropenia/" class="peer">Febrile Neutropenia</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="febrile-neutropenia" tabindex="-1">febrile neutropenia</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/notes/">notes</a></li>
</ul>
<h2 id="neutropenic-prophylaxis" tabindex="-1">Neutropenic prophylaxis</h2>
<ul>
<li>antiviral: acyclovir if HSV+</li>
<li>antifungal
<ul>
<li>fluconazole if on cytarabine/venetoclax</li>
<li>posaconazole if on 7+3, cytarabine/daunorubicin/midaustaurin</li>
</ul>
</li>
<li>antibacterial
<ul>
<li>moxifloxacin inpatient</li>
<li>levofloxacin ambulatory</li>
</ul>
</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/photo5123275537903626305.jpg" alt=""></p>
<ul>
<li>maintain gram negative coverage until ANC resolves</li>
</ul>
<p>![](<a href="https://photos.thisispiggy.com/fi">https://photos.thisispiggy.com/fi</a></p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/TTP/" class="peer">TTP</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="ttp" tabindex="-1">TTP</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220813142839.png" alt="">
<img src="https://photos.thisispiggy.com/file/wikiFiles/20220810211426.png" alt="">
This patient likely has <strong>thrombotic thrombocytopenic purpura</strong> (TTP), which is characterized by the formation of small-vessel, platelet-rich thrombi due to severe deficiency of the von Willebrand factor–cleaving protein ADAMTS13.  TTP can be associated with pregnancy due to the formation of autoantibod</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/disseminated intravascular coagulation/" class="peer">Disseminated Intravascular Coagulation</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="disseminated-intravascular-coagulation" tabindex="-1">disseminated intravascular coagulation</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/DIC%20vs%20liver%20disease/">DIC vs liver disease</a></li>
<li>tags: #note</li>
</ul>
<h2 id="common-causes" tabindex="-1">Common Causes</h2>
<p>Common Causes</p>
<ul>
<li>sepsis: not that common</li>
<li>most common: malignancy (APL), B cell malignancies</li>
<li>pregnancy/delivery, amniotic fluid</li>
</ul>
<h2 id="pathogenesis" tabindex="-1">Pathogenesis</h2>
<ul>
<li>exposure to TF  =&gt; thrombosis =&gt; clotting</li>
<li>dysregulation of coagulation system: everything ramped up. More coagulation and fibrinolysis</li>
</ul>
<h2 id="stage-1" tabindex="-1">Stage 1</h2>
<ul>
<li>PT/PTT: normal/low</li>
<li>microthrombi, schisctocytes</li>
<li>A</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/leukostasis/" class="peer">Leukostasis</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="leukostasis" tabindex="-1">leukostasis</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<p>Leukostasis</p>
<ul>
<li>blasts &gt; 50 with symptoms</li>
<li>
<blockquote>
<p>80 concerning</p>
</blockquote>
</li>
<li>
<blockquote>
<p>100 ppx leukopheresis</p>
</blockquote>
</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/tumor lysis syndrome/" class="peer">Tumor Lysis Syndrome</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="tumor-lysis-syndrome" tabindex="-1">tumor lysis syndrome</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><strong>Tumor lysis syndrome (TLS)</strong> occurs when a <mark>large tumor burden undergoes rapid destruction</mark> with release of its intracellular contents into the bloodstream.  Resulting electrolyte and metabolic abnormalities can cause <mark>acute kidney injury</mark> (eg, <mark>calcium-phosphate precipitation</mark> in renal tubules), <mark>arrhythmias</mark> (eg, <mark>calcium-phosphate precipitation in the heart</mark>), <mark>seizures</mark>, and possible sudde</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/anemia lecture/" class="peer">Anemia Lecture</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="anemia-lecture" tabindex="-1">anemia lecture</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<hr>
<ul>
<li>
<p>MCV</p>
<ul>
<li>changes with age</li>
<li><img src="https://photos.thisispiggy.com/file/wikiFiles/20210602153415.png" alt=""></li>
</ul>
</li>
<li>
<p>macrocytosis: defect in DNA synthesis</p>
</li>
<li>
<p>microcytosis: defect in hemoglobin synthesis</p>
</li>
</ul>
<h2 id="ida" tabindex="-1">IDA</h2>
<ul>
<li>blood loss: GI work up, menopause</li>
<li>increased requirements: pregnancy/lactation</li>
<li>decreased dietary intake</li>
<li>decreased absorption: celiac, gastric bypass</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20210602154059.png" alt=""></p>
<h2 id="treat" tabindex="-1">Treat</h2>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/blood smear/" class="peer">Blood Smear</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="blood-smear" tabindex="-1">blood smear</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<hr>
<h2 id="overview" tabindex="-1">Overview</h2>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20210602133947.png" alt="">
<img src="https://photos.thisispiggy.com/file/wikiFiles/20210602134004.png" alt=""></p>
<ul>
<li>look in monolayer region, red cells not overlapping but almost touching</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20210602134333.png" alt=""></p>
<h2 id="terminology" tabindex="-1">Terminology</h2>
<ul>
<li>background: not significant</li>
<li>trace: not totally confident real finding</li>
<li>1+ first step with confidence abnormal</li>
<li>4+</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/essential thrombocytosis/" class="peer">Essential Thrombocytosis</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="essential-thrombocytosis" tabindex="-1">essential thrombocytosis</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20210602150459.png" alt=""></p>
<ul>
<li>questions to ask
<ul>
<li>splenomegaly</li>
<li>menstrual hx</li>
<li>hx of clots</li>
<li>family hx</li>
</ul>
</li>
<li>sx
<ul>
<li><img src="https://photos.thisispiggy.com/file/wikiFiles/20210602151439.png" alt=""></li>
</ul>
</li>
<li>labs
<ul>
<li>iron profile</li>
<li>esr/crp</li>
<li>ldh</li>
<li>uric acid</li>
<li>JAK2: V617F, exon 12</li>
<li>CALR</li>
<li>MPL</li>
</ul>
</li>
</ul>
<p>Patients with ET are often asymptomatic but can develop vasomotor symptoms (eg, headaches, dizziness,</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/polycythemia vera/" class="peer">Polycythemia Vera</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="polycythemia-vera" tabindex="-1">polycythemia vera</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/essential%20thrombocytosis/">essential thrombocytosis</a></li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20210602143437.png" alt=""></p>
<ul>
<li>erythrocytosis</li>
<li>questions to ask
<ul>
<li>smoking history</li>
<li>hormonal therapy (testosterone increases Hgb)</li>
<li>OSA hx</li>
<li>renal/liver cancer</li>
<li>burning pain in hands/feet</li>
<li>itching</li>
<li>fatigue</li>
</ul>
</li>
<li>physical exam findings
<ul>
<li>facial plethora</li>
<li>red extremities</li>
<li>clubbing</li>
<li>splenomegaly</li>
</ul>
</li>
<li>labs
<ul>
<li>iron profile</li>
<li>LDL</li>
<li>uric acid</li>
<li>EPO</li>
</ul>
</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/DIC vs liver disease/" class="peer">DIC vs Liver Disease</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="dic-vs-liver-disease" tabindex="-1">DIC vs liver disease</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #note</li>
</ul>
<hr>
<ul>
<li>Check factor 8</li>
<li>Produced by endothelial cells</li>
<li>Increased in liver disease: released as liver cells are destroyed</li>
<li>Decreased in DIC: activated protein C proleolyses factor 8</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/anticoagulation reversal/" class="peer">Anticoagulation Reversal</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="anticoagulation-reversal" tabindex="-1">anticoagulation reversal</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="pradaxa-(dabigatran)" tabindex="-1">Pradaxa (dabigatran)</h2>
<p>Use Praxbind (idarucizumab) for Pradaxa reversal. Dialysis is alternative but could take too long and could have problem with vas cath insertion when bleeding.</p>
<p>Check PTT and thrombin time if available</p>
<h2 id="eliquis-and-xarelto" tabindex="-1">Eliquis and Xarelto</h2>
<p>Use Kcentra or FEIBA for reversal.</p>
<ul>
<li>FEIBA is 4 factor concentrates: 2, 7, 9, 10</li>
<li>Kcentra has 2, 7, 9, 10 but also protein C and S but could take longer</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/massive transfusion protocol/" class="peer">Massive Transfusion Protocol</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="massive-transfusion-protocol" tabindex="-1">massive transfusion protocol</h1>
<ul>
<li>related: <a href="/wiki/notes/transfusion%20medicine/">transfusion medicine</a>, <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<ul>
<li>Ratio 1:1:1:1: pRBC, FFP, plt, cryo</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220208105112.png" alt=""></p>
<ul>
<li><a href="/wiki/notes/hypocalcemia%20is%20common%20abnormality%20after%20massive%20transfusion/">hypocalcemia is common abnormality after massive transfusion</a></li>
</ul>
<hr>
<h2 id="literature-notes" tabindex="-1">Literature Notes</h2>
<ul>
<li><a href="/wiki/notes/ibcc%20massive%20transfusion%20protocol/">ibcc massive transfusion protocol</a></li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/prevention of recurrent VTE in cancer patients/" class="peer">Prevention of Recurrent VTE in Cancer Patients</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="prevention-of-recurrent-vte-in-cancer-patients" tabindex="-1">prevention of recurrent VTE in cancer patients</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>Patients with cancer have a 4-7 fold increased risk of venous thromboembolism (VTE).  Long-term VTE treatment is different in cancer patients than patients without cancer.  <mark>Low molecular weight heparin</mark> (LMWH) is <mark>more effective than vitamin K antagonists</mark> (e.g., warfarin) in <mark>reducing the risk of recurrent VTE in cancer patients</mark> (while on therapy), and they do not signific</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/autoimmune hemolytic anemia/" class="peer">Autoimmune Hemolytic Anemia</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="autoimmune-hemolytic-anemia" tabindex="-1">autoimmune hemolytic anemia</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<!-- warm vs cold AIHA cause, sx, rx -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220530145620.png" alt="">
This patient's presentation suggests <mark>autoimmune hemolytic anemia</mark> (AIHA), a complication in about 10% of patients with <mark>systemic lupus erythematosus</mark> (SLE).  AIHA is due to autoantibodies (warm agglutinins or IgG antibodies and cold agglutinins or IgM antibodies) destroying red blood c</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/supratherapeutic INR/" class="peer">Supratherapeutic INR</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="supratherapeutic-inr" tabindex="-1">supratherapeutic INR</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<!-- managing supratherapeutic INR -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220531140455.png" alt=""></p>
<p>Patients on warfarin therapy are at risk for <strong>elevated INR</strong> due to drug interactions, vitamin K deficiency, and superimposed conditions (eg, <strong>diarrhea</strong>, fever, liver disease, heart failure).  Impaired cognition, depression, or low literacy can also lead to elevated INR due to incorrect warfarin</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/management of bone metastasis/" class="peer">Management of Bone Metastasis</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="management-of-bone-metastasis" tabindex="-1">management of bone metastasis</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<!-- medical management of bone mets -->
<p>In patients with <strong>bone metastases</strong>, <mark>osteoclast-inhibiting agents</mark> such as <mark>denosumab</mark> and <mark>bisphosphonates</mark> significantly <mark>decrease the risk of **skeletal-related events</mark>** (SREs) (eg, fracture, skeletal instability/loss, spinal cord compression) and can delay symptom onset, fracture formation, need for irradiation, development of hypercalcemia,</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Breast Cancer/" class="peer">Breast Cancer</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="breast-cancer" tabindex="-1">Breast Cancer</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/breast%20nodule%20and%20mass/">breast nodule and mass</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="introduction" tabindex="-1">Introduction</h2>
<p>Breast cancer is the most common type of cancer in women in the United States, excluding skin cancers. In 2015, there were an estimated 231,840 new invasive breast cancer cases and 60,290 in situ cases diagnosed. The lifetime risk of developing invasive breast cancer is 12.4% (about 1 in 8) for U.S. women. There were an estimated 40,290 deaths from breast cancer in the</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Cancer of Unknown Primary Site/" class="peer">Cancer of Unknown Primary Site</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="cancer-of-unknown-primary-site" tabindex="-1">Cancer of Unknown Primary Site</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="introduction" tabindex="-1">Introduction</h2>
<p>Despite steady improvements in diagnostic and imaging techniques during the past decades, a reasonable evaluation will not identify the source of cancer in a small number (less than 5%) of all patients presenting with metastatic cancer. This heterogeneous group of patients is classified as having cancer of unknown primary (CUP). As diagnostic imaging continues to improve, the freq</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Effects of Cancer Therapy and Survivorship/" class="peer">Effects of Cancer Therapy and Survivorship</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="effects-of-cancer-therapy-and-survivorship" tabindex="-1">Effects of Cancer Therapy and Survivorship</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="effects-of-cancer-therapy" tabindex="-1">Effects of Cancer Therapy</h2>
<h3 id="hematologic-toxicity" tabindex="-1">Hematologic Toxicity</h3>
<p>The major toxicity of many traditional chemotherapeutic agents remains myelosuppression, leading to anemia, neutropenia, and thrombocytopenia.</p>
<h4 id="neutropenia-and-fever" tabindex="-1">Neutropenia and Fever</h4>
<p>The risk of infection increases with the magnitude and the duration of neutropenia, which typically occurs 5 to 15 days after chemotherapy administration. Serio</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Erythrocyte Disorders/" class="peer">Erythrocyte Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="erythrocyte-disorders" tabindex="-1">Erythrocyte Disorders</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="approach-to-anemia" tabindex="-1">Approach to Anemia</h2>
<p>Anemia is a pathologic state resulting in an insufficient number of erythrocytes to deliver oxygen to organs and tissues. Anemia can arise from blood loss, underproduction of erythrocytes, destruction of erythrocytes (hemolysis), or a combination of these factors. Patients with chronic anemia may be entirely asymptomatic or may experience symptoms of dyspnea, decreased exercise toler</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Gastroenterological Malignancies/" class="peer">Gastroenterological Malignancies</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="gastroenterological-malignancies" tabindex="-1">Gastroenterological Malignancies</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="colorectal-cancer" tabindex="-1">Colorectal Cancer</h2>
<p>Colorectal cancer (CRC) is the fourth most common cancer and the second leading cause of cancer death in North America, yet it is largely preventable through screening. CRC screening of average-risk patients is discussed in <a href="https://mksap18.acponline.org/app/topics/gm/mk18_b_gm_s3/mk18_b_gm_s3_2_3_5_3">MKSAP 18 General Internal Medicine</a>. ==Most colon cancers are adenocarci</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Genitourinary Cancer/" class="peer">Genitourinary Cancer</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="genitourinary-cancer" tabindex="-1">Genitourinary Cancer</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="prostate-cancer" tabindex="-1">Prostate Cancer</h2>
<h3 id="epidemiology-and-risk-factors" tabindex="-1">Epidemiology and Risk Factors</h3>
<p>Adenocarcinoma of the prostate remains one of the most commonly diagnosed types of cancer among men in the United States, with an estimated lifetime risk of one in seven. Age is a very important risk factor; prostate cancer is rarely diagnosed before age 40 years, but after that point, the incidence increases significantly. Ethnicity is also an importan</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Head and Neck Cancer/" class="peer">Head and Neck Cancer</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="head-and-neck-cancer" tabindex="-1">Head and Neck Cancer</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>Head and neck cancers include primary tumors of the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, paranasal sinuses, thyroid, and salivary glands. Squamous cell carcinoma is the most common form of head and neck cancer and is therefore the focus of this chapter. Thyroid cancer is discussed in [MKSAP 18 Endocrinology and Metabolism](<a href="https://mksap18.acponline.org/app/topics/en/mk18_b_en_s4/mk18_b">https://mksap18.acponline.org/app/topics/en/mk18_b_en_s4/mk18_b</a></p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Hematologic Issues in Pregnancy/" class="peer">Hematologic Issues in Pregnancy</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="hematologic-issues-in-pregnancy" tabindex="-1">Hematologic Issues in Pregnancy</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="gestational-anemia" tabindex="-1">Gestational Anemia</h2>
<p>During pregnancy, an increase in plasma volume occurs that is greater than the increase in erythrocyte mass, resulting in a physiologic decrease in measured hemoglobin level, although it typically remains greater than 10.5 g/dL (105 g/L). If the hemoglobin level decreases further, additional evaluation of the anemia is warranted. Iron, vitamin B12, and folate levels should</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Hematopoietic Stem Cells and Their Disorders/" class="peer">Hematopoietic Stem Cells and Their Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="hematopoietic-stem-cells-and-their-disorders" tabindex="-1">Hematopoietic Stem Cells and Their Disorders</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="overview" tabindex="-1">Overview</h2>
<p>Hematopoietic stem cells nest in the bone marrow and have the capacity to differentiate and self-renew. Hematopoietic stem cells are multipotent and can differentiate into progenitor cells; in turn, these produce leukocytes, erythrocytes, and platelets. This differentiation and proliferation to mature blood cells happens in an orderly manner called hematopoiesis. Hematop</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Iron Overload Syndromes/" class="peer">Iron Overload Syndromes</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="iron-overload-syndromes" tabindex="-1">Iron Overload Syndromes</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="primary%2Fhereditary-hemochromatosis" tabindex="-1">Primary/Hereditary Hemochromatosis</h2>
<h4 id="related-question" tabindex="-1">Related Question</h4>
<ul>
<li>Question 26</li>
</ul>
<p>Hereditary hemochromatosis (HH) is the most common inherited genetic disorder in Whites, with a prevalence of 1 in 250 persons of northern European descent. Approximately 85% to 90% of patients with HH are homozygous for the C282Y mutation in the <em>HFE</em> gene; the remaining patients are typically compound heterozygotes for C282Y a</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Issues in Oncology/" class="peer">Issues in Oncology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="issues-in-oncology" tabindex="-1">Issues in Oncology</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="introduction" tabindex="-1">Introduction</h2>
<p>Technological advances are changing the field of medical oncology at a rapid rate. The successful incorporation of immune checkpoint inhibitors and other immunologic strategies to facilitate activation of the patient's own immune system as part of the standard treatment of many malignancies has been a major advance. Other changes include expanded routine use of molecular profiling in several</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Lung Cancer/" class="peer">Lung Cancer</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="lung-cancer" tabindex="-1">Lung Cancer</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>This section will focus on treatment and follow-up of patients with lung cancer. See <a href="https://mksap18.acponline.org/app/topics/pm/mk18_b_pm_s7/mk18_b_pm_s7_2">MKSAP 18 Pulmonary and Critical Care Medicine</a> for discussion of epidemiology, screening, clinical manifestations, diagnosis, and staging of patients with lung cancer. Initial biopsy can distinguish tumors as either non–small cell lung cancer (NSCLC) or small</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Lymphoid Malignancies/" class="peer">Lymphoid Malignancies</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="lymphoid-malignancies" tabindex="-1">Lymphoid Malignancies</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="epidemiology-and-risk-factors" tabindex="-1">Epidemiology and Risk Factors</h2>
<p>The American Cancer Society estimates that in 2018 83,180 new cases of lymphoma will be diagnosed in the United States. The lifetime risk of developing non-Hodgkin lymphoma is 2.1%, whereas the lifetime risk of developing Hodgkin lymphoma is considerably less. Although incidence has only slightly declined recently, death rates have decreased significantly owing to improvem</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/MKSAP Bleeding Disorders/" class="peer">MKSAP Bleeding Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="mksap-bleeding-disorders" tabindex="-1">MKSAP Bleeding Disorders</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="normal-hemostasis" tabindex="-1">Normal Hemostasis</h2>
<p>Hemostasis is the process by which bleeding is controlled through a complex network of prothrombotic and fibrinolytic activity. Clot generation occurs on phospholipid membranes through the activation of procoagulant factors (<strong><a href="https://mksap18.acponline.org/app/topics/ho/figures/mk18_a_ho_f17">Figure 17</a></strong>). Traditionally, the process was described as a waterfall coagulation cascad</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/MKSAP Cervical Cancer/" class="peer">MKSAP Cervical Cancer</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="mksap-cervical-cancer" tabindex="-1">MKSAP Cervical Cancer</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="epidemiology-and-risk-factors" tabindex="-1">Epidemiology and Risk Factors</h2>
<p>In 2018, there will be an estimated 13,240 new patients diagnosed with invasive cervical cancer and 4170 deaths from cervical cancer in the United States. The mean age of diagnosis in the United States is 48 years. During the last 30 years, cervical cancer incidence and deaths in developed countries have decreased by more than 50%, primarily because of screening and preven</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/MKSAP Transfusion Medicine/" class="peer">MKSAP Transfusion Medicine</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="mksap-transfusion-medicine" tabindex="-1">MKSAP Transfusion Medicine</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>Clinical trials supporting the benefits of a more cautious transfusion strategy have dramatically changed transfusion practice. For elective transfusions, ABO and Rh matching based on a properly labeled blood specimen remains the cornerstone of safe transfusion. Approximately 5% to 10% of hospitalized patients have evidence of erythrocyte alloimmunization from previous transfusions, pregnancy, or orga</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Melanoma/" class="peer">Melanoma</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="melanoma" tabindex="-1">Melanoma</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>Melanoma has been steadily increasing in incidence worldwide, with risk related to sun exposure. Most melanomas begin in and present with cutaneous disease, but they can also begin in mucosal sites. About half arise in preexisting nevi, but many begin in apparently normal skin. Melanoma can also present in nodal or visceral sites without a known cutaneous or mucosal primary. About 10% of patients with melanoma have a f</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Multiple Myeloma and Related Disorders/" class="peer">Multiple Myeloma and Related Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="multiple-myeloma-and-related-disorders" tabindex="-1">Multiple Myeloma and Related Disorders</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="overview" tabindex="-1">Overview</h2>
<p>B-cell maturation to plasma cells involves early antigen-independent and antigen-dependent phases. When humoral immunity is stimulated by an infection or inflammation, multiple clones of plasma cells are expanded. These plasma cell clones can produce immunoglobulins of different classes and specificity, giving the characteristic polyclonal spike seen on protein electrophoresis</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Oncologic Urgencies and Emergencies/" class="peer">Oncologic Urgencies and Emergencies</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="oncologic-urgencies-and-emergencies" tabindex="-1">Oncologic Urgencies and Emergencies</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="structural-urgencies-and-emergencies" tabindex="-1">Structural Urgencies and Emergencies</h2>
<h3 id="superior-vena-cava-syndrome" tabindex="-1">Superior Vena Cava Syndrome</h3>
<p>Obstruction of the superior vena cava (SVC), or SVC syndrome, occurs in approximately 15,000 persons in the United States each year. Most cases are caused by malignancies with large mediastinal masses. Patients typically present with edema of the head, neck, and arms, often with cyanosis, plethora, and distended cutaneo</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Ovarian Cancer/" class="peer">Ovarian Cancer</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="ovarian-cancer" tabindex="-1">Ovarian Cancer</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="epidemiology-and-risk-factors" tabindex="-1">Epidemiology and Risk Factors</h2>
<h4 id="related-question" tabindex="-1">Related Question</h4>
<ul>
<li>Question 86</li>
</ul>
<p>Ovarian cancer, the leading cause of gynecologic cancer deaths, will be newly diagnosed in approximately 22,000 women in 2016 in the United States, with an estimated 14,000 deaths. This chapter will focus on the 95% of ovarian cancers that are of epithelial origin.</p>
<p>Risk factors for ovarian epithelial cancer include inheritance of ovarian can</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Platelet Disorders/" class="peer">Platelet Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="platelet-disorders" tabindex="-1">Platelet Disorders</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="normal-platelet-physiology" tabindex="-1">Normal Platelet Physiology</h2>
<p>Platelets are cell fragments released from megakaryocytes that circulate in an inactive state in the blood for 8 to 10 days. One third of the platelets are sequestered in the spleen and released back into the circulation in response to epinephrine.</p>
<p>Platelet activation, the first step in hemostasis, occurs in a three-stage process. Platelets adhere to exposed subendothelial surf</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Thrombotic Disorders/" class="peer">Thrombotic Disorders</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="thrombotic-disorders" tabindex="-1">Thrombotic Disorders</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>The burden of venous thromboembolic disease continues to increase despite increased awareness of risk factors and prevention options. The incidence of a first episode of venous thromboembolism (VTE) is approximately 1 to 2 per 1000 person/years.</p>
<p>VTE most commonly manifests as lower extremity deep venous thrombosis (DVT) or pulmonary embolism (PE). Many nosocomial VTEs are preventable, although thromboproph</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/breast nodule and mass/" class="peer">Breast Nodule and Mass</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="breast-nodule-and-mass" tabindex="-1">breast nodule and mass</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/Breast%20Cancer/">Breast Cancer</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>A palpable breast mass is a common presenting symptom of breast cancer.  Breast masses that are firm, immobile, irregularly shaped, and accompanied by lymphadenopathy, nipple discharge, or skin changes are concerning for malignancy.  However, history and physical examination are not sufficient to diagnose or exclude malignancy, and further evaluation with imaging is required.</p>
<p>In **wome</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/metastatic colon cancer to liver/" class="peer">Metastatic Colon Cancer to Liver</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="metastatic-colon-cancer-to-liver" tabindex="-1">metastatic colon cancer to liver</h1>
<ul>
<li>related: <a href="/wiki/notes/GI/">GI</a>, <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220802213740.png" alt=""></p>
<p>Approximately 20% of patients with <strong>colorectal cancer</strong> have metastatic disease at diagnosis.  Common sites include the liver, lung, peritoneum, and lymph nodes.  Most cases are incurable, but patients with <strong>liver-isolated colorectal cancer</strong> can sometimes be cured with <strong>surgical resection</strong>.  Surgery can generally</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/anterior mediastinal mass/" class="peer">Anterior Mediastinal Mass</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="anterior-mediastinal-mass" tabindex="-1">anterior mediastinal mass</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>The differential diagnosis for an anterior mediastinal mass includes the &quot;4 T's&quot;:</p>
<ul>
<li>thymoma</li>
<li>teratoma</li>
<li>thyroid neoplasm</li>
<li>terrible lymphoma</li>
</ul>
<p>Within the category of teratoma, one must also include other germ cell tumors.  Teratomas can often be distinguished from other germ cell tumors on imaging by the presence of <strong>fat</strong> or <strong>calcium</strong>, particularly if in the form of a tooth.  Serum hormone levels</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/myelofibrosis/" class="peer">Myelofibrosis</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="myelofibrosis" tabindex="-1">myelofibrosis</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220810193652.png" alt=""></p>
<p>This patient has normocytic anemia, massive splenomegaly, and teardrop cells on peripheral smear.  These findings are consistent with primary myelofibrosis (PMF).  Primary myelofibrosis is a chronic myeloproliferative disorder characterized by an overproduction of megakaryocytes and bone marrow stromal cells, which release fibrosis-promoting cy</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/comparing different anticoagulants, warfarin, coumadin, doacs/" class="peer">Comparing Different Anticoagulants, Warfarin, Coumadin, Doacs</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="comparing-different-anticoagulants%2C-warfarin%2C-coumadin%2C-doacs" tabindex="-1">comparing different anticoagulants, warfarin, coumadin, doacs</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220812220912.png" alt=""></p>
<p>Systemic thromboembolism is a major cause of long-term morbidity in patients with atrial fibrillation.  Treatment with <strong>warfarin</strong> or <strong>target-specific oral anticoagulants</strong> (TSOACs: dabigatran, rivaroxaban, apixaban, edoxaban) has been shown to significantly reduce the risk of embolization in pa</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/long term complications of non hodgkin lymphoma/" class="peer">Long Term Complications of Non Hodgkin Lymphoma</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="long-term-complications-of-non-hodgkin-lymphoma" tabindex="-1">long term complications of non hodgkin lymphoma</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220812202056.png" alt=""></p>
<p>Non-Hodgkin lymphoma (NHL) survivors are at increased risk for many long-term complications such as second malignancies, cardiovascular disease, endocrine problems, and neuro-psychiatric complications.  As the risk of NHL relapse decreases after five years of treatment, long-term care of these patients is incre</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/perioperative management of von willebrand disease vwd vwf/" class="peer">Perioperative Management of Von Willebrand Disease Vwd Vwf</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="perioperative-management-of-von-willebrand-disease-vwd-vwf" tabindex="-1">perioperative management of von willebrand disease vwd vwf</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/Perioperative/">Perioperative</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220812152833.png" alt=""></p>
<p><strong>Von Willebrand disease</strong> (VWD) is the most common inherited bleeding disorder.  <strong>Type 1 VWD</strong> accounts for 75% of cases and is marked by a <strong>quantitive deficiency</strong> of von Willebrand factor (VWF), leading to low VWF antigen, VWF activity, and factor VIII levels.  Patients with b</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/treat solitary lung brain mets with surgical resection/" class="peer">Treat Solitary Lung Brain Mets with Surgical Resection</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="treat-solitary-lung-brain-mets-with-surgical-resection" tabindex="-1">treat solitary lung brain mets with surgical resection</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220813092306.png" alt=""></p>
<p>Nearly 40% of patients with systemic cancer develop <strong>brain metastases</strong>, usually through hematogenous spread.  Imaging features suggesting metastatic disease include circumscribed margins, location at the gray-white matter junction, patterns of vasogenic edema, and multiple lesions.  The most common und</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/acquired coagulation factor inhibitors/" class="peer">Acquired Coagulation Factor Inhibitors</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="acquired-coagulation-factor-inhibitors" tabindex="-1">acquired coagulation factor inhibitors</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<!-- acquired coagulation factor inhibitor sx, examples -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220903103912.png" alt=""></p>
<p>The coagulation studies reveal a normal PT and a prolonged <strong>aPTT</strong>, which  is indicative of an <strong>intrinsic pathway disorder</strong> and is the typical  pattern seen in patients with hemophilia A and B, von Willebrand  disease, and certain acquired disorders. Becaus</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/acute bleeding classifications/" class="peer">Acute Bleeding Classifications</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="acute-bleeding-classifications" tabindex="-1">acute bleeding classifications</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>Use heart rate and urine output as initial assessment of volume loss. Patients with tachycardia and decreased urine output have at least 30% blood loss and are labelled as Class III or IV acute hemorrhage. They may have confusion and decreased pulse pressure. Consider replace with blood products besides volume expansion.</p>
<ul>
<li>[[transfusing chronical anemic patients to hemoglobin goal can cause worse</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/anticoagulation agents/" class="peer">Anticoagulation Agents</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="anticoagulation-agents" tabindex="-1">anticoagulation agents</h1>
<ul>
<li>related: <a href="/wiki/notes/coagulation%20cascade/">coagulation cascade</a>, <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/7bmxLd7.jpg" alt=""></p>
<ul>
<li>Warfarin is a Vitamin K antagonist. Vitamin K is required for Factor 2, 7, 9, 10, C, S</li>
<li>DOACS are direct oral anticoagulants. They are divided into 10a inhibitors and IIa inhibitors</li>
<li>10a inhibitors:
<ul>
<li>Apixaban (Eliquis)</li>
<li>Rivaroxaban (Xarelto)</li>
</ul>
</li>
<li>2a inhibitors:
<ul>
<li>dabigatran (Pradaxa)</li>
<li>argatroban</li>
</ul>
</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/coagulation cascade/" class="peer">Coagulation Cascade</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="coagulation-cascade" tabindex="-1">coagulation cascade</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/anticoagulation%20agents/">anticoagulation agents</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<h2 id="coagulation" tabindex="-1">Coagulation</h2>
<ul>
<li>Coagulation happens with
<ul>
<li>endothelin release from site of damage leading to vasoconstriction</li>
<li>endothelial damage leads to platelet activation leading to thrombus</li>
<li>endothelial damage leads to coagulation factor activation. Fibrin is formed leading to thrombus</li>
</ul>
</li>
</ul>
<h2 id="cascade" tabindex="-1">Cascade</h2>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/PuA5Ke2.jpg" alt=""></p>
<p>Coagulation cascade has</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/hypocalcemia is common abnormality after massive transfusion/" class="peer">Hypocalcemia Is Common Abnormality After Massive Transfusion</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="hypocalcemia-is-common-abnormality-after-massive-transfusion" tabindex="-1">hypocalcemia is common abnormality after massive transfusion</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/massive%20transfusion%20protocol/">massive transfusion protocol</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<ul>
<li>blood products have citrate preservative that binds to endogenous calcium after transfusion, leading to <a href="/wiki/notes/hypocalcemia/">hypocalcemia</a></li>
<li>hypocalcemia can cause coagulopathy</li>
<li>don't wait for hypocalcemia on labs. Aim for mildly elevated calcium levels in massive transfusion</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220903101324.png" alt=""></p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/use mixing studies to differentiate deficiency vs inhibitors/" class="peer">Use Mixing Studies to Differentiate Deficiency vs Inhibitors</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="use-mixing-studies-to-differentiate-deficiency-vs-inhibitors" tabindex="-1">use mixing studies to differentiate deficiency vs inhibitors</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220615144524.png" alt=""></p>
<p>Prolonged aPTT and normal PT (INR) suggest an intrinsic pathway defect.  Deficiencies of factor XII, prekallikrein, or high molecular weight kininogen all cause a prolonged aPTT without clinical bleeding.  Prolonged aPTT with bleeding can occur in congenital or acquired von Willebrand disease and i</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/ibcc anemia, bleeding, transfusion/" class="peer">Ibcc Anemia, Bleeding, Transfusion</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="ibcc-anemia%2C-bleeding%2C-transfusion" tabindex="-1">ibcc anemia, bleeding, transfusion</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/transfusion%20medicine/">transfusion medicine</a></li>
<li>tags: #literature</li>
<li>source: <a href="https://emcrit.org/ibcc/transfusion">https://emcrit.org/ibcc/transfusion</a>, <a href="https://emcrit.org/ibcc/gib/">https://emcrit.org/ibcc/gib/</a></li>
</ul>
<hr>
<h2 id="nonbleeding" tabindex="-1">Nonbleeding</h2>
<ul>
<li>anemia panel is not useful in acute ICU hemoglobin drop</li>
<li>Iron supplementation not helpful in ICU anemia</li>
<li>transfusion can cause worsening hyperkalemia</li>
<li>transfuse dialysis patients during dialysis</li>
</ul>
<h2 id="gi-bleed" tabindex="-1">GI bleed</h2>
<ul>
<li>normal Hgb with unstable hemodynamics more worrisome than a</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/transfuse rbc for goal of 7 for stable hospitalized patients or 8 for cardiac or surgical patients/" class="peer">Transfuse Rbc for Goal of 7 for Stable Hospitalized Patients or 8 for Cardiac or Surgical Patients</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="transfuse-rbc-for-goal-of-7-for-stable-hospitalized-patients-or-8-for-cardiac-or-surgical-patients" tabindex="-1">transfuse rbc for goal of 7 for stable hospitalized patients or 8 for cardiac or surgical patients</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a>, <a href="/wiki/notes/transfusion%20goals/">transfusion goals</a></li>
<li>tags: #permanent</li>
</ul>
<hr>
<p>For stable, nonbleeding, hospitalized patients, transfusion goal should be 7. For stable, nonbleeding, hospitalized patients who have preexisting coronary artery disease or are undergoing surgery, transfusion goal should be 8 or if patient is symptomatic (chest pain, tachycardia, hypotension). No transfusi</p>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//" class="peer"></a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="medicine" tabindex="-1">Medicine</h1>
<ul>
<li>Related: <a href="/wiki/notes/Step%201/">Step 1</a>, <a href="/wiki/notes/mksap/">mksap</a>, <a href="/wiki/notes/notes/">notes</a></li>
</ul>
<h2 id="todos" tabindex="-1">Todos</h2>
<ul>
<li><a href="/wiki/notes/tolearn/">tolearn</a></li>
</ul>
<h2 id="organ-systems" tabindex="-1">Organ Systems</h2>
<ul>
<li><a href="/wiki/notes/Allergy%20and%20Immunology/">Allergy and Immunology</a></li>
<li><a href="/wiki/notes/Rheumatology/">Rheumatology</a></li>
<li><a href="/wiki/notes/Cardiology/">Cardiology</a></li>
<li><a href="/wiki/notes/Dermatology/">Dermatology</a></li>
<li><a href="/wiki/notes/Endocrine/">Endocrine</a></li>
<li><a href="/wiki/notes/ENT/">ENT</a></li>
<li><a href="/wiki/notes/GI/">GI</a></li>
<li><a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li><a href="/wiki/notes/ID/">ID</a></li>
<li><a href="/wiki/notes/MSK/">MSK</a></li>
<li><a href="/wiki/notes/Nephrology/">Nephrology</a></li>
<li><a href="/wiki/notes/Urology/">Urology</a></li>
<li><a href="/wiki/notes/Neurology/">Neurology</a></li>
<li><a href="/wiki/notes/Pulmonology/">Pulmonology</a></li>
<li><a href="/wiki/notes/Podiatry/">Podiatry</a></li>
</ul>
<h2 id="subject-areas" tabindex="-1">Subject Areas</h2>
<ul>
<li><a href="/wiki/notes/General/">General</a></li>
<li><a href="/wiki/notes/Biostats/">Biostats</a></li>
<li><a href="/wiki/notes/Psychiatry/">Psychiatry</a></li>
<li><a href="/wiki/notes/Geriatrics/">Geriatrics</a></li>
<li><a href="/wiki/notes/OBGYN/">OBGYN</a></li>
<li><a href="/wiki/notes/Pediatric/">Pediatric</a></li>
<li>[</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
